NCT04720599View on ClinicalTrials.gov

Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 1, 2021

Study Completion Date

June 1, 2021

Conditions
Urologic Cancer
Interventions
DIAGNOSTIC_TEST

ExoDx Prostate(IntelliScore)

The ExoDx Prostate test result supports the biopsy decision process by stratifying patients based on risk for high grade prostate cancer

Trial Locations (3)

21204

Chesapeake Urology Research Associates, Baltimore

08043

New Jersey Urology, Voorhees Township

Unknown

Klinikum der Universität München, München

Sponsors
All Listed Sponsors
lead

Exosome Diagnostics, Inc.

INDUSTRY

NCT04720599 - Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy | Biotech Hunter | Biotech Hunter